By contrast, in our report, among 591 patients, which included early stage, intermediate stage and late stage, from 7 years of follow up, patients’ groups with positive AQP5 expression carried (212 cases) a less favorable breast cancer specific survival rate (Fig 2). The gene discussed is AQP5; the disease is breast carcinoma.